Xuliang Wang

Title: Xuliang Wang: Innovator in Pharmaceutical Chemistry

Introduction

Xuliang Wang is a prominent inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug compounds. With a total of 2 patents to his name, Wang's work focuses on innovative solutions for medical applications.

Latest Patents

Wang's latest patents include a benzamide derivative, which is described as a drug composition that holds potential therapeutic uses. The invention relates to a general formula I, where the definitions of R, Z, and Q are specified in the detailed description. Another notable patent involves pyrazolo[3,4-c]pyridine derivatives. This patent discloses a compound of formula (I), along with its tautomers, optical isomers, or pharmaceutically acceptable salts. These compounds exhibit the ability to inhibit the Xa factor, making them valuable for preparing medications aimed at preventing and treating conditions associated with low bleeding risk.

Career Highlights

Xuliang Wang is currently employed at Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His role at this esteemed company allows him to further his research and development efforts in the pharmaceutical sector. Wang's innovative spirit and dedication to advancing medical science have positioned him as a key figure in his field.

Collaborations

Wang collaborates with talented colleagues, including Ying Shi and Yi Mi. These partnerships enhance the research environment and foster the exchange of ideas, contributing to the success of their projects.

Conclusion

Xuliang Wang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to innovation in medicine. His work continues to pave the way for new therapeutic options that can improve patient outcomes.